Epidemiology of atrial fbrillation: European perspective

Clinical Epidemiology

Volumn 6, Issue 1, 2014, Pages 213-220

  Zoni Berisso, Massimo ^a   Lercari, Fabrizio ^a   Carazza, Tiziana ^a   Domenicucci, Stefano ^a  

^a Padre A Micone Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EUROPE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; PREVALENCE; PROGNOSIS; SEX RATIO; VALVULAR HEART DISEASE;

EID: 84902576977     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S47385     Document Type: Article

References (48)

1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fbrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Europace. 2006;8:651-745.
2. Eurostat Methodologies and Working papers. Work Session on Demographic Progressions. Lisbon, Portugal, April 28-30, 2010.
3. Go AS, Hylek EM, Philips KA, et al. Prevalence of diagnosed atrial fbrillation in adults: national implication for rhythm management and stroke prevention. The AnTicoagulation and RIsk factors in Atrial fbrillation (ATRIA) study. JAMA. 2001;285:2370-2375.
4. Murphy N F, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fbrillation in Scotland. Heart. 2007;93:606-612.
5. Ruskin JN, Singh J P. Atrial fbrillation endpoints: hospitalizations. Heart Rhythm. 2004;1 July Suppl:B31-B35.
6. Santini M, De Ferrari GM, Pandozi C, et al; For the FIRE Investigators. Atrial fbrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/ Flutter Italian Registry (FIRE). Ital Heart J. 2004;5:205-213.
7. Friberg L, Bergfeldt L. Atrial fbrillation prevalence revisited. J Intern Med. 2013;274:461-468.
8. Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15:486-493.
9. Zoni-Berisso M, Filippi A, Landolina M, et al. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fbrillation [From the Italian Survey of Atrial Fibrillation Management (ISAF) Study]. Am J Cardiol. 2013;111:705-711.
10. Piccini J P, Hammil BG, Sinner M F, et al. Incidence and prevalence of atrial fbrillation and associated mortality among Medicare benefciaries: 1993-2007. Circ Cardiovasc Qual Outcomes. 2012;5:85-93.
11. Stefansdottir H, Appelund T, Gudnason V, Adnar DO. Trends in the incidence and prevalence of atrial fbrillation in Iceland and future projection. Europace. 2011;13:1110-1117.
12. Cowan C, Healicon R, Robson I, et al. The use of anticoagulants in the management of atrial fbrillation among general practices in England. Heart. 2013;99:1166-1172.
13. Fitzmaurice DA, Hobbs DR, Jowet S, et al. Screening versus routine practice in detection of atrial fbrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335:386-391.
14. Rho RW, Page RL. Asymptomatic atrial fbrillation. Progr Cardiovasc Dis. 2005;48:78-87.
15. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fbrillation: a global burden of disease study. Circulation. 2014;129:837-847.
16. Gomez-Doblas JJ, Muniz J, Alonso Martin JJ, et al. Prevalence of atrial fbrillation in Spain. OFRECE study results. Rev Esp Cardiol. 2014;67(4):259-269.
17. Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fbrillation: the Framingham Study. N Engl J Med. 1982;306:1018-1022.
18. Myasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fbrillation in Olmsted County, Minnesota, 1980 to 2000, and the implications on the future prevalence. Circulation. 2006;114: 119-125.
19. Meinertz T, Kirch, Rosin L, Pittrow D, Wilich SN, Kirchof P.; ATRIUM Investigators. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol. 2011;100:897-905.
20. Nabauer M, Gerth A, Limbourg T, et al. The Registry of German Competence Network on atrial fbrillation: patient characteristics and initial management. Europace. 2009;11:423-434.
21. Nieuwlaat R, Capucci A, Camm AJ, et al; European Heart Survey Investigators. Atrial fbrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422-2434.
22. Di Pasquale G, Mathieu G, Maggioni A P, et al. On behalf of ATA-AF Investigators. Current presentation and management of 7148 patients with atrial fbrillation in cardiology and internal medicine hospital centers: the ATA-AF study. Int J Cardiol. 2013;167:2895-2903.
23. Levy S, Maarek M, Coumel P, et al; On behalf of the College of French Cardiologists. Characterization of different subsets of atrial fbril-lation in general practice in France. The ALFA study. Circulation. 1999;99:3028-3035.
24. Chiang CE, Naditch-Brulé L, Murin J, et al. Distribution and risk profle of paroxysmal, persistent, and permanent atrial fbrillation in routine clinical practice. insight from the real-life global survey evaluating patients with atrial fbrillation international registry. Circ Arrhythm Electrophysiol. 2012;5:632-639.
25. McManus DD, Rienstra M, Benjamin EJ. An update on the prognosis of patients with atrial fbrillation. Circulation. 2012;126:e143-e146.
26. Nieuwlaat R, Prins MH, Le Heuzey JY, et al. Prognosis, disease progression, and treatment of atrial fbrillation patients during 1 year. Follow up of the Euro Heart Survey on atrial fbrillation. Eur Heart J. 2008;29:1181-1189.
27. De Sisti A, Leclercq JF, Halimi F, Fiorello P, Bertrand C, Attuel P. Evaluation of time course predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fbrillation. Pacing Clin Electrophysiol. 2014;37:345-355.
28. Kerr CR, Humphries KH, Talajic M, et al. Progression to chronic atrial fbrillation after the initial diagnosis of paroxysmal atrial fbrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149:489-496.
29. Jahangir A, Lee V, Friedman PA, et al. Long-term progression and outcomes with aging in patients with lone atrial fbrillation, A 30-year follow up study. Circulation. 2007;115:3050-3056.
30. De Voos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fbrillation. Clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725-731.
31. Self WH, Wasserman BS, McNaughton CD, Darbar D. Evaluating the HATCH score for predicting progression to sustained atrial fbrillation in ED patients with new atrial fbrillation. Am J Emerg Med. 2013;31:792-797.
32. American Heart Association. Heart and Stroke Statistical Update. Dallas, TX, USA: American Heart Association; 1999. Available from: http://www.nanocorthx.com/Articles/HeartDiseaseStrokeStatistics.pdf. Accessed May 29, 2014.
33. Wolf PA, Abbott RD, Kannel WB. Atrial fbrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
34. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fbril-lation: report from the Stockolm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31:967-972.
35. Shroff GR, Solid CA, Herzog CA. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fbrillation: a 15-year perspective (1992-2007). JAMA Intern Med. 2013;173:159-160.
36. Friberg L, Rosenqvist M, Lip GYH. Net clinical beneft of warfarin use in patients with atrial fbrillation: a report of the Swedish Atrial Fibrillation Cohort Study. Circulation. 2012;125:2298-2307.
37. Cotté FE, Chaize G, Kachaner I, Gaudin A F, Vainchtock A, Durand-Zaleski L. Incidence and cost of stroke and haemorrhage in patients diagnosed with atrial fbrillation. J Stroke Cerebrovasc Dis. 2014;23:73-83.
38. Ott AO, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hoffman A. Atrial fbrillation and dementia in a population-based study. Stroke. 1997;28:316-321.
39. Cha MJ, Park H, Lee MH, Cho Y, Choi EK, Oh S. Prevalence and risk factors for silent ischemic stroke in patients with atrial fbrillation as determined by brain magnetic resonance imaging. Am J Cardiol. 2014;113:656-661.
40. Anter E, Jessup M, Callans DJ. Atrial fbrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119: 2516-2525.
41. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fbrillation and congestive heart failure and their joint infuence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925.
42. Mountantonakis SE, Grau-Sepulveda M V, Bhatt DL, Hernandez A F, Peterson ED, Fonarow GC. Presence of atrial fbrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get with the Guidelines - Heart Failure. Circ Heart Fail. 2012;5:191-201.
43. Chamberlain AM, Redfeld MM, Alonso A, Weston SA, Roger VL. Atrial fbrillation and mortality in heart failure: a community study. Circ Heart Fail. 2011;4:740-746.
44. Andersson T, Magnuson A, Bryngelson IL, et al. All cause mortality in 272186 patients hospitalized with incident atrial fbrillation1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34:1061-1067.
45. Myasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with frst atrial fbrillation: a 2 1-year community-based study. J Am Coll Cardiol. 2007;49:986-992.
46. Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fbrillation. JAMA. 2011;305:2080-2087.
47. Benerjee A, Taillandier S, Olesen JB, et al. Pattern of atrial fbrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int J Cardiol. 2013;167:2682-2687.
48. Krijthe B P, Kunst A, Benjamin EJ, et al. Projections of the number of individuals with atrial fbrillation in the European Union from 2000 to 2060. Eur Heart J. 2013;34:2746-2751.